Signaling pathways
-
BA7837 BMS-986242Summary: BMS-986242 is an orally active, potent and selective inhibitor of indoleamine-2,3-dioxygenase1. - BA7838 IDO-IN-5Summary: IDO-IN-5 (NLG-1489) is an indoleamine-2,3-dioxygenase inhibitor.
- BA7839 IDO-IN-8Summary: IDO-IN-8 (NLG-1487) is an indoleamine-2,3-dioxygenase inhibitor.
- BA7840 IDO1-IN-18Summary: IDO1-IN-18 is a potent inhibitor.
- BA7841 IDO-IN-6Summary: IDO-IN-6 (NLG-1486) is an indoleamine-2,3-dioxygenase inhibitor.
- BA7842 NLG802Summary: NLG802 is a precursor of indoximod.
- BA7843 IDO-IN-13Summary: IDO-IN-13 is a potent inhibitor.
- BA7844 Roxyl-9Summary: An IDO1 (Indoleamine2,3-dioxygenase1) inhibitor.
- BA7845 CAY10581Summary: CAY10581 is a pyranaphthoquinone derivative.
-
BA7847 VorasidenibSummary: Vorasidenib (AG-881) is an orally available, brain-permeable, second-generation dual inhibitor of mutant isocitrate dehydrogenase 1 and 2.